Kara (Dixon) Capriotte, M.D. Curriculum Vitae

Find Out More About Her Education, Experience, and Awards in the Philaelphia, Bryn Mawr, and Newtown Square Areas and Beyond

EDUCATION

Chief Resident Dermatology, Thomas Jefferson University, Philadelphia, PA 2008-2009
Residency Dermatology, Thomas Jefferson University, Philadelphia, PA 2006-2009
Medical Intern, Albert Einstein Medical Center, Philadelphia, PA 2005-2006
Medical Doctor, Drexel University College of Medicine, Philadelphia, PA 2005
B.S. Neuroscience, University of Pittsburgh, 2000.

LICENSURE

Diplomat, Micrographic Dermatologic Surgery 2021

Diplomat, American Board of Dermatology 2009

Fellow, American Academy of Dermatology 2009

PUBLICATIONS

Capriotti K. Nasal and Oral Decontamination is Vital in Mitigating the Spread of COVID-19. J Clinic Exper Cosmet Derma. 2020;3:09.

Capriotti K, Anadkat M, Choi J, Kaffenberger B, McLellan B, Goldfarb S, Barone S, Kuyoki O, Lacouture M. A Randomized Phase 2 Trial of the Efficacy and Safety of a Novel Topical Povidone-Iodine Formulation for Cancer Therapy-Associated Paronychia. Invest New Drugs. 2019 Dec; 37(6);1247-1256.

Pelletier JS, Capriotti K, Barone SB, Devine J, Capriotti JA. Topical Application of Povidone-Iodine / Dimethylsulfoxide Ophthalmic Gel Preparation in Dutch-Belted Rabbits. Ocular Cutaneous Toxicology, 2019 Feb 10:1-11.

Capriotti J, Pelletier J, Capriotti K, Barone S. “Efficacy of Topical Ophthalmic Agent VBP-100 Against Multi-Drug Resistant Biofilms of Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa and Candida albicans.” [abstract] Investigative Ophthalmology & Visual Science. 2018;59: 3653.

Tessema B, Wycherly B, Arumugam S, Capriotti K, Pelletier J, Barone S, Capriotti J. Efficacy of Dilute Povidone-Iodine Preparations Against Multi-Drug Resistant Biofilms of Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa and Candida albicans. Paripex – Indian Journal of Research. 2018;7:376-377.

Capriotti K, Stewart K, Pelletier J, Capriotti J. Efficacy of Dilute Povidone-Iodine Against Multi-Drug Resistant BioFilms and Fungal Spores. Clin Res Derm 2018; 5(1): 1-5.

Capriotti K, Pelletier J, Barone S, Nuckolls C, Capriotti J. (2017). Povidone-Iodine as Treatment for Human Papillomavirus. In Human Papillomavirus Infection (pp. 1-10). Retrieved from http://openaccessebooks.com/human-papillomavirus.html

Capriotti K. Dermatologist calls for shift on treating ocular disease. Dermatology News, 2017 Vol 48(8):32.

Capriotti K, Stewart K, Pelletier J, Capriotti J. Chemotherapy-Associated Paronychia Treated With Dilute Povidone-Iodine: A Series of Cases. Cancer Management and Research 2017:9 225–228.
Pelletier J, Capriotti K, Stewart K, Capriotti J. Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report. Ophthalmol Ther, 2017 Jun 22. doi: 10.1007/s40123-017-0097-3. [Epub ahead of print]

Capriotti K, Stewart K, Pelletier J, Capriotti J. Molluscum Contagiosum Treated With Dilute Povidone-Iodine: A Series of Cases. Jour Clin Aesthet Derm, 2017 Vol 10(3):41-45.

Capriotti K, Stewart KP, Pelletier JS, Capriotti J. Tinea Pedis/Gram-Negative Toe Web Infection Treated With a Dilute Povidone-Iodine and Dimethylsulfoxide Preparation. Scientific Pages Dermatol, 2017 Vol 1(1):6-7.

Capriotti K, Stewart KP, Pelletier JS, Capriotti J. Treatment of Onychomycosis With Dilute Topical Povidone-Iodine in a Dimethylsulfoxide Solvent System. Jour Clin Res Trial, 2016.

Capriotti K, Stewart K, Pelletier J, Capriotti J. Molluscum Contagiousm Viral Infection Treated With a Dilute Povidone-Iodine/Dimethylsulfoxide Preparation. Dermatol Ther, 2016 Mar;6(1):101-3.

Capriotti K, Stewart KP, Pelletier JS, Capriotti J. A Novel 2% Povidone-Iodine Solution for the treatment of Common Warts: A Randomized, Double-Blind, Vehicle-Controlled Trial. Dermatol Ther, 2015 Dec;5(4):247-252.

Pelletier JS, Stewart KP, Capriotti K, Capriotti JA. Rosacea Blepharoconjunctivits Treated with a Novel Preparation of Dilute Povidone-Iodine and Dimethylsuloxide: a Case Report and Review of the Literature. Ophthalmol Ther, 2015 Dec;4(2):143-50.

Capriotti K, Capriotti JA. Onychomycosis Treated With a Dilute Povidone Iodine / Dimethylsulfoxide Preparation. 2015 Int Med Case Rep J, Oct 8;8:231-3.

Capriotti K, Capriotti JA. Chemotherapy-Associated Paronychia Treated With a Dilute Povidone Iodine / Dimethylsulfoxide Preparation. Clin Cosmet and Investig Dermatol, 2015 Sept 21;8:489-91.

Capriotti K, Capriotti JA, Lessin S, Wu S, Goldfarb S, Belum VR, Lacouture M. The risk of nail changes with taxane chemotherapy: A systematic review of the literature and meta-analysis. Br J of Dermatol 2015 Sep;173(3):842-5.

Capriotti K. The Road to Rx: Navigating the journey of drug development from a physician’s perspective. Young Physician Focus, a publication of the American Academy of Dermatology, Fall 2014 issue.

Capriotti K, Capriotti JA. Topical iodophor preparations: chemistry, microbiology, and clinical utility. Dermatol Online J, 2012 Nov 15;18(11):1.

Capriotti K, Capriotti JA. Dimethyl Sulfoxide: History, Chemistry and Clinical Utility in Dermatology Dimethyl Sulfoxide: History, Chemistry and Clinical Utility in Dermatology. Jour Clin Aesthet Derm, 2012 Sep;5(9):24-6.

Capriotti K, Humphreys T. A Novel Extraction Technique for Large Lipomas. Dermatol Surg, 2009 Mar;35(3):493-5.

Capriotti K, Lee J, Hyde P. Allergic contact granuloma: an uncommon reaction to pierced earrings in a child. Pediatr Dermatol, 2009 Sep-Oct;26(5):620-1.

L Geskin, K Dixon, A Kingston, S McCann, J Plowey, M Robb and L Falo. An engineered autologous dendritic cell therapy induced potent tumor specific t-cell activity and clinical response in a patient with end-stage cutaneous t-cell lymphoma. J. Invest. Derm, Vol 122: A51, March 2004.

INVITED LECTURES AND PRESENTATIONS

MASCC/ISOO 2019 Annual Meeting on Supportive Care in Cancer Late Breaking Research Presentation “A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of Topical Povidone-Iodine in Cancer-Therapy Associated Paronychia,” selected presenter, San Francisco, CA, June 2019.

MASCC/ISOO 2017 Annual Meeting on Supportive Care in Cancer Late Breaking Research Presentation “Chemotherapy Associated Paronychia Treated With Dilute Povidone-Iodine: A Series of Cases,” selected presenter, Washington, DC June 2017.

American Academy of Dermatology Spring 2017 Annual Research Symposium Late Breaking Research Presentation “Molluscum Contagiosum Treated With Dilute Povidone-Iodine: A Series of Cases,” selected presenter, Orlando, FL March 2017.

Dermatology Entrepreneurial Conference Shark Tank Competition Finalist “Clinical Stage Dermatology Company with Multiple Programs in Unmet Therapeutic Areas,” San Francisco, CA, March 2015.

American Academy of Dermatology Spring 2015 Annual Research Symposium “Povidone-Iodine Nail Solution is Active in Treating Chemotherapy-Associated Paronychia,” San Francisco, CA, March 2015.

American Academy of Dermatology Spring 2014 Annual Research Symposium “Povidone-Iodine Nail Solution is Active in Treating Onychomycosis,” Denver, CO, March 2014.

American Academy of Dermatology Spring 2014 Annual Research Symposium “Paronychia requiring intervention in patients receiving taxanes: A review of the literature,” Denver, CO, March 2014.

“Common Skin Issues in the Senior Population,” Quadrangle Senior Living Facility, August 2010.

American Academy of Dermatology Spring 2008 Annual Research “Allergic Contact Granuloma: A Rare Reaction to Ear Piercing,” San Antonio, TX, March 2008.

Philadelphia Dermatologic Society Meeting. “Allergic Contact Granuloma: A Rare Reaction to Ear Piercing,” Philadelphia, PA Sept 2007.

Pennsylvania Academy of Dermatology “Allergic Reactions Associated with Ear Piercing: A Case Report and Review of the Literature,” Hershey, PA October 2007.

American Academy of Dermatology Summer 2004 Annual Research Symposium “Treatment of Sezary Syndrome Patient with Dendritic Cell Immunotherapy Results in Immune and Clinical Responses,” New York, New York 2004.

“Development of Dendritic Cell Immunotherapies for Cutaneous T Cell Lymphoma,” Dermatology and Immunology Grand Rounds University of Pittsburgh, May 2004.

MEDIA

American Academy of Dermatology Spring 2017 Annual Research Symposium featured in Dermatology World coverage: https://aadmeetingnews.org/2017-annual-meeting-dailies/new-gel-effective-in-treating-molluscum-contagiosum/

Exploring your options for Age Spot Treatments. Main Line Health Blog, May 20, 2016. https://blog.mainlinehealth.org/community/exploring-your-options-for-age-spot-treatment/

“Drug Development for the Practicing Physician,” featured contributor for Next Steps in Dermatology, an online publication sponsored by Aveeno, running November and December 2015.

Mainline Health Women’s Video Series, “Anti-Aging Therapies: The Facts,” Featured Dermatologist on video series, August 2012.

AWARDS

“Top Doc in Dermatology, Philadelphia Magazine 2018, 2019, 2020, 2021
“Top Doc of the Main Line in Dermatology” Main Line Times 2015, 2018, 2019, 2020, 2021
“People’s Choice Award” in Dermatology 2015, 2016, 2017, 2018, 2019, 2020, 2021
“Top Resident” Thomas Jefferson University, June 2009.
Alpha Omega Alpha Honor Society Member, inducted May 2005.
American Medical Women’s Association Award for Outstanding Scholastic Achievement 2005.
Altoona Family Physicians Scholarship April 2003.
Hahnemann Alumni Scholarship Recipient July 2000.
Summa Cum Laude Graduate, University of Pittsburgh 2000.
Phi Beta Kappa Honor Society, University of Pittsburgh 2000.
Lambda Sigma National Honor Society, University of Pittsburgh 1998.
Dean’s List in all Semesters 1996-2000.
University of Pittsburgh Presidential Scholar 1996-2000.

RESEARCH EXPERIENCE

Cutaneous Oncology Research Fellowship
Louis Falo, MD, PhD, Chairman

July 2003-July 2004

University of Pittsburgh School of Medicine, Department of Dermatology

Developed human in vitro dendritic cell immunotherapies for Cutaneous T-Cell Lymphoma (CTCL), specifically Sezary Syndrome (SzS). Loaded dendritic cells with antigens derived from whole tumor cells that were isolated from blood of SzS patients, assessed them for maturation potential and tumor specific T-Cell responses in vitro. Performed clinical trial in which eligible patients with SzS were given Dendritic Cell derived vaccines and then assessed for clinical response. Prepared two Investigational New Drug Applications based on data gathered from in vitro research: 1) In vitro Evaluation of Immune Responses in Sezary Syndrome and 2) Randomized Phase I/II Evaluation of Immunization Against Tumor Cells in Subjects with Sezary Syndrome using Autologous Mature Dendritic Cells.

Department of Plastic Surgery
Student Research Technician
Adam Katz, MD, PhD
University of Pittsburgh School of Medicine

Aug 1998-April 1999

AFFILIATIONS

American Society of Mohs Surgeons, Fellow, 2010-present
American Society of Dermatologic Surgery, Fellow, 2009-present
American Academy of Dermatology, Fellow, 2009- present
American Medical Student Association Member, 2000-2005
American Medical Association Member, 2005-present